Annual EBIT
-$112.87 M
-$2.83 M-2.58%
December 31, 2023
Summary
- As of March 3, 2025, FDMT annual earnings before interest & taxes is -$112.87 million, with the most recent change of -$2.83 million (-2.58%) on December 31, 2023.
- During the last 3 years, FDMT annual EBIT has fallen by -$56.20 million (-99.19%).
- FDMT annual EBIT is now -985.36% below its all-time high of -$10.40 million, reached on December 31, 2018.
Performance
FDMT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$51.13 M
-$8.68 M-20.44%
September 30, 2024
Summary
- As of March 3, 2025, FDMT quarterly earnings before interest & taxes is -$51.13 million, with the most recent change of -$8.68 million (-20.44%) on September 30, 2024.
- Over the past year, FDMT quarterly EBIT has dropped by -$37.16 million (-265.91%).
- FDMT quarterly EBIT is now -573.14% below its all-time high of -$7.60 million, reached on June 30, 2021.
Performance
FDMT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$168.38 M
-$37.16 M-28.32%
September 30, 2024
Summary
- As of March 3, 2025, FDMT TTM earnings before interest & taxes is -$168.38 million, with the most recent change of -$37.16 million (-28.32%) on September 30, 2024.
- Over the past year, FDMT TTM EBIT has dropped by -$63.44 million (-60.46%).
- FDMT TTM EBIT is now -1316.59% below its all-time high of -$11.89 million, reached on September 30, 2019.
Performance
FDMT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
FDMT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.6% | -265.9% | -60.5% |
| 3 y3 years | -99.2% | -265.9% | -60.5% |
| 5 y5 years | -985.4% | -265.9% | -60.5% |
FDMT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.2% | at low | -265.9% | at low | -136.0% | at low |
| 5 y | 5-year | -147.4% | at low | -573.1% | at low | -497.6% | at low |
| alltime | all time | -985.4% | at low | -573.1% | at low | -1316.6% | at low |
4D Molecular Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$51.13 M(+20.4%) | -$168.38 M(+28.3%) |
| Jun 2024 | - | -$42.46 M(+11.3%) | -$131.22 M(+8.5%) |
| Mar 2024 | - | -$38.14 M(+4.0%) | -$120.90 M(+7.1%) |
| Dec 2023 | -$112.87 M(+2.6%) | -$36.65 M(+162.3%) | -$112.87 M(+7.6%) |
| Sep 2023 | - | -$13.97 M(-56.5%) | -$104.94 M(-10.7%) |
| Jun 2023 | - | -$32.14 M(+6.7%) | -$117.46 M(+3.3%) |
| Mar 2023 | - | -$30.11 M(+4.8%) | -$113.75 M(+3.4%) |
| Dec 2022 | -$110.03 M(+54.3%) | -$28.72 M(+8.4%) | -$110.03 M(+3.7%) |
| Sep 2022 | - | -$26.50 M(-6.8%) | -$106.08 M(+3.7%) |
| Jun 2022 | - | -$28.43 M(+7.7%) | -$102.24 M(+25.6%) |
| Mar 2022 | - | -$26.39 M(+6.6%) | -$81.41 M(+14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$71.33 M(+25.9%) | -$24.76 M(+9.3%) | -$71.33 M(+6.5%) |
| Sep 2021 | - | -$22.66 M(+198.3%) | -$66.99 M(+28.5%) |
| Jun 2021 | - | -$7.60 M(-53.4%) | -$52.15 M(-12.7%) |
| Mar 2021 | - | -$16.31 M(-20.1%) | -$59.70 M(+5.4%) |
| Dec 2020 | -$56.66 M(+24.2%) | -$20.42 M(+161.3%) | -$56.66 M(+7.9%) |
| Sep 2020 | - | -$7.82 M(-48.4%) | -$52.53 M(-7.2%) |
| Jun 2020 | - | -$15.15 M(+14.1%) | -$56.60 M(+36.5%) |
| Mar 2020 | - | -$13.28 M(-18.5%) | -$41.45 M(+47.1%) |
| Dec 2019 | -$45.63 M(+338.8%) | -$16.29 M(+37.0%) | -$28.17 M(+137.0%) |
| Sep 2019 | - | -$11.89 M | -$11.89 M |
| Dec 2018 | -$10.40 M(-7.7%) | - | - |
| Dec 2017 | -$11.27 M | - | - |
FAQ
- What is 4D Molecular Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual EBIT year-on-year change?
- What is 4D Molecular Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly EBIT year-on-year change?
- What is 4D Molecular Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics TTM EBIT year-on-year change?
What is 4D Molecular Therapeutics annual earnings before interest & taxes?
The current annual EBIT of FDMT is -$112.87 M
What is the all time high annual EBIT for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual earnings before interest & taxes is -$10.40 M
What is 4D Molecular Therapeutics annual EBIT year-on-year change?
Over the past year, FDMT annual earnings before interest & taxes has changed by -$2.83 M (-2.58%)
What is 4D Molecular Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of FDMT is -$51.13 M
What is the all time high quarterly EBIT for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly earnings before interest & taxes is -$7.60 M
What is 4D Molecular Therapeutics quarterly EBIT year-on-year change?
Over the past year, FDMT quarterly earnings before interest & taxes has changed by -$37.16 M (-265.91%)
What is 4D Molecular Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of FDMT is -$168.38 M
What is the all time high TTM EBIT for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high TTM earnings before interest & taxes is -$11.89 M
What is 4D Molecular Therapeutics TTM EBIT year-on-year change?
Over the past year, FDMT TTM earnings before interest & taxes has changed by -$63.44 M (-60.46%)